Jaguar Health, Inc.
JAGX
$1.89
-$0.10-5.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.96% | -3.67% | 6.80% | 4.96% | 19.77% |
| Total Depreciation and Amortization | -3.94% | -6.25% | -1.26% | -1.79% | 1.02% |
| Total Amortization of Deferred Charges | -100.00% | -100.00% | -97.93% | -86.28% | -8.41% |
| Total Other Non-Cash Items | 104.28% | 111.74% | 166.24% | 1,181.66% | 70.58% |
| Change in Net Operating Assets | 103.15% | 86.11% | 72.88% | 51.45% | -117.82% |
| Cash from Operations | 6.05% | 2.28% | 11.61% | 9.95% | 13.24% |
| Capital Expenditure | 100.00% | -- | -- | -- | -433.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,243.75% | -- | -- | 95.57% | 96.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 16.31% | 18.56% | 25.71% | 16.94% | 35.29% |
| Issuance of Common Stock | -68.99% | -21.02% | -0.85% | 56.88% | 23.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -109.06% | -113.59% | -107.09% | 1.16% | -0.66% |
| Cash from Financing | -62.11% | -13.67% | -8.84% | 54.76% | 8.68% |
| Foreign Exchange rate Adjustments | 1,460.00% | 102.78% | -460.00% | 84.00% | -116.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -286.50% | -121.92% | 53.30% | 236.92% | 2,017.83% |